Meuwissen et al. generated the original SCLC GEMM by lung-specific compound deletion of the TP53 and RB1 genes and showed that complete loss of these genes led to the development of SCLC tumors, resembling and recapitulating many characteristics of human SCLC tumors [20]. The gene discussed is TP53; the disease is small cell lung carcinoma.